Description - Cognition and Cancer by Christina A. Meyers
Most people afflicted by cancer will experience cognitive impairment, sometimes referred to as 'chemobrain' or 'chemofog', due to the various direct and indirect effects of their disease and its treatment. In addition, patients with primary or metastatic tumors of the brain experience direct neurologic symptoms due, for example, to the location of their disease, surgical intervention, and the late effects of treatment such as radiotherapy. The aim of this book is to serve as a resource for health care professionals working with cancer patients who experience cognitive changes as a result of their cancer and its treatment. It provides practical information to help improve care by reviewing and describing brain-behavior relationships; research-based evidence on cognitive changes that occur with various cancers and cancer treatments; assessment techniques, including neurocognitive assessment and neuroimaging techniques; and intervention strategies for affected patients. In short, it will explain how to identify, assess and treat these conditions.
Buy Cognition and Cancer by Christina A. Meyers from Australia's Online Independent Bookstore, Boomerang Books.
(253mm x 192mm x 21mm)
Cambridge University Press
Publisher: Cambridge University Press
Country of Publication:
Other Editions - Cognition and Cancer by Christina A. Meyers
Book Reviews - Cognition and Cancer by Christina A. Meyers
» Have you read this book? We'd like to know what you think about it - write a review about Cognition and Cancer book by Christina A. Meyers and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a Boomerang Books Account Holder - it's free to sign up and there are great benefits!)
Author Biography - Christina A. Meyers
Christina A. Meyers is Professor and Chief of the Section of Neuropsychology, Department of Neuro-Oncology at The University of Texas M.D. Anderson Cancer Center, Houston, Texas. James R. Perry holds the Tony Crolla Chair in Brain Tumour Research and is Head of the Division of Neurology at the Sunnybrook Health Sciences Centre and Odette Cancer Centre, University of Toronto, Canada.